KYMR
Kymera Therapeutics, Inc.
Company overview
- Market capitalization
- $9.31B
- Employees
- 253
- Latest publication
- 2026-09-29
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing KT-621, an oral STAT6 degrader in Phase 2b clinical trials for moderate to severe atopic dermatitis, asthma, COPD, EoE, CRSwNP, CSU, PN, BP, and others; KT-579, an oral IRF5 degrader in Phase 1 trials for autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, SSc, DM, and others; KT-485/SAR447971, IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis; and cyclin-dependent kinase 2 (CDK2) with broad oncology treatment potential, including in breast cancer and other solid tumors. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 65,000,000USD | 34,365,000USD | 2,860,000USD | 2,764,000USD | 11,476,000USD | 22,100,000USD | 7,394,000USD | 3,741,000USD |
| Cost Of Revenue | 65,000,000USD | 2,021,999USD | -76,178,000USD | 74,094,000USD | 2,084,000USD | 2,048,000USD | 1,973,000USD | 2,000,000USD |
| Gross Profit | 0USD | 34,365,000USD | 79,038,000USD | -71,330,000USD | 9,392,000USD | 22,100,000USD | 7,394,000USD | 3,741,000USD |
| Research Development | 119,481,000USD | 98,162,000USD | 83,863,000USD | 74,094,000USD | 78,388,000USD | 80,255,000USD | 71,817,000USD | 60,410,000USD |
| Selling General Administrative | 21,126,000USD | 20,357,000USD | 16,948,000USD | 17,336,000USD | 17,645,000USD | 16,271,000USD | 16,332,000USD | 15,455,000USD |
| General And Administrative Expenses | 21,126,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 140,607,000USD | 118,519,000USD | 176,934,000USD | 21,191,000USD | 93,949,000USD | 96,526,000USD | 88,149,000USD | 75,865,000USD |
| Operating Income | -75,607,000USD | -84,154,000USD | -97,896,000USD | -92,521,000USD | -84,557,000USD | -74,426,000USD | -80,755,000USD | -72,124,000USD |
| Total Other Income Expense Net | 14,396,000USD | 14,920,000USD | 10,643,000USD | 10,346,000USD | 7,943,000USD | 8,845,000USD | 10,003,000USD | 9,637,000USD |
| Net Income | -61,211,000USD | -69,234,000USD | -87,030,000USD | -82,175,000USD | -76,614,000USD | -65,581,000USD | -70,752,000USD | -62,487,000USD |
| Net Income Applicable To Common Shares | -61,211,000USD | — | — | — | — | — | — | — |
| Interest Income | — | 14,981,000USD | 11,005,000USD | 10,444,000USD | 8,051,000USD | 8,917,000USD | 10,062,000USD | 9,697,000USD |
| Interest Expense | — | 61,000USD | 69,000USD | 98,000USD | 108,000USD | 72,000USD | 59,000USD | 60,000USD |
| Net Interest Income | — | 14,920,000USD | 10,915,000USD | 10,346,000USD | 7,943,000USD | 8,845,000USD | 10,003,000USD | 9,637,000USD |
| Income Before Tax | — | -69,234,000USD | -87,253,000USD | -82,175,000USD | -76,614,000USD | -65,581,000USD | -70,752,000USD | -62,487,000USD |
| Net Income From Continuing Ops | — | -69,234,000USD | -86,981,000USD | -82,175,000USD | -76,614,000USD | -65,581,000USD | -70,752,000USD | -62,487,000USD |
| Ebit | — | -69,173,000USD | -87,184,000USD | -82,175,000USD | -76,506,000USD | -65,509,000USD | -70,693,000USD | -62,427,000USD |
| Ebitda | — | -67,151,000USD | -85,152,000USD | -79,326,000USD | -74,422,000USD | -63,461,000USD | -68,706,000USD | -60,440,000USD |
| Depreciation And Amortization | — | 2,022,000USD | 2,032,000USD | 2,849,000USD | 2,084,000USD | 2,048,000USD | 1,987,000USD | 1,987,000USD |
| Reconciled Depreciation | — | 2,022,000USD | 2,032,000USD | 2,149,000USD | 2,084,000USD | 2,048,000USD | 1,987,000USD | 1,987,000USD |
| Unclassified Operating Expenses | — | — | 76,123,000USD | -70,239,000USD | -2,084,000USD | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | -2,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 39,200,000USD | 47,072,000USD | 78,592,000USD | 46,826,000USD | 72,832,000USD | 34,034,000USD | 2,934,000USD | 0USD |
| Gross Profit | 39,200,000USD | 47,072,000USD | 78,592,000USD | 46,826,000USD | 72,832,000USD | 34,034,000USD | 2,109,000USD | -205,000USD |
| Research Development | 316,600,000USD | 240,248,000USD | 189,081,000USD | 164,248,000USD | 137,017,000USD | 62,105,000USD | 37,158,000USD | 17,679,000USD |
| Selling General Administrative | 68,200,000USD | 63,534,000USD | 55,041,000USD | 43,834,000USD | 36,345,000USD | 18,233,000USD | 7,981,000USD | 3,772,000USD |
| Total Operating Expenses | 388,600,000USD | 308,707,000USD | 244,122,000USD | 208,082,000USD | 173,362,000USD | 80,338,000USD | 45,139,000USD | 21,451,000USD |
| Operating Income | -349,400,000USD | -261,635,000USD | -165,530,000USD | -161,256,000USD | -100,530,000USD | -46,304,000USD | -42,205,000USD | -21,451,000USD |
| Interest Income | 38,418,000USD | 38,026,000USD | 18,764,000USD | 6,624,000USD | 488,000USD | 826,000USD | 1,005,000USD | 0USD |
| Interest Expense | 249,000USD | 249,000USD | 196,000USD | 176,000USD | 175,000USD | 115,000USD | 46,000USD | 16,000USD |
| Net Interest Income | 38,048,000USD | 37,777,000USD | 18,568,000USD | 6,448,000USD | 313,000USD | 711,000USD | 959,000USD | -16,000USD |
| Income Before Tax | -311,623,000USD | -223,858,000USD | -146,962,000USD | -154,808,000USD | -100,217,000USD | -45,593,000USD | -41,246,000USD | -21,467,000USD |
| Net Income | -311,400,000USD | -223,858,000USD | -146,962,000USD | -154,808,000USD | -100,217,000USD | -45,593,000USD | -41,292,000USD | -21,467,000USD |
| Net Income From Continuing Ops | -311,351,000USD | -223,858,000USD | -146,962,000USD | -154,808,000USD | -100,217,000USD | -45,593,000USD | -41,246,000USD | -21,467,000USD |
| Ebit | -311,374,000USD | -223,609,000USD | -146,766,000USD | -154,632,000USD | -100,042,000USD | -45,478,000USD | -41,200,000USD | -21,451,000USD |
| Ebitda | -303,061,000USD | -216,236,000USD | -143,201,000USD | -151,655,000USD | -97,645,000USD | -43,715,000USD | -40,375,000USD | -21,246,000USD |
| Depreciation And Amortization | 8,313,000USD | 7,373,000USD | 3,565,000USD | 2,977,000USD | 2,397,000USD | 1,763,000USD | 825,000USD | 205,000USD |
| Reconciled Depreciation | 8,313,000USD | 7,373,000USD | 3,565,000USD | 2,977,000USD | 2,397,000USD | 1,763,000USD | 825,000USD | 205,000USD |
| Total Other Income Expense Net | 37,777,000USD | 37,777,000USD | 18,568,000USD | 6,448,000USD | 313,000USD | 711,000USD | 959,000USD | -16,000USD |
| Cost Of Revenue | — | 7,373,000USD | 189,081,000USD | 2,977,000USD | 2,397,000USD | 62,105,000USD | 825,000USD | 205,000USD |
| Unclassified Operating Expenses | — | 4,925,000USD | — | — | — | — | — | — |
| Income Tax Expense | — | — | 18,764,000USD | -2,977,000USD | -2,222,000USD | -1,648,000USD | 46,000USD | 43,859USD |
| Non Operating Income Net Other | — | — | — | 6,448,000USD | 313,000USD | 711,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -154,808,000USD | -100,217,000USD | -54,643,000USD | -41,246,000USD | -21,467,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,645,444,000USD | 1,669,016,000USD | 1,742,812,000USD | 1,102,044,000USD | 1,131,068,000USD | 918,312,000USD | 978,035,000USD | 1,034,842,000USD |
| Cash And Equivalents | 124,477,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 737,265,000USD | 677,432,000USD | 871,214,000USD | 528,298,000USD | 728,327,000USD | 500,951,000USD | 510,268,000USD | 568,715,000USD |
| Other Current Assets | 26,280,000USD | 26,503,000USD | 22,938,000USD | 22,616,000USD | 22,882,000USD | 17,801,000USD | 20,577,000USD | 17,428,000USD |
| Other Non Current Assets | 7,385,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 136,188,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 71,326,000USD | 62,643,000USD | 83,212,000USD | 71,575,000USD | 87,540,000USD | 58,989,000USD | 67,767,000USD | 66,532,000USD |
| Other Current Liabilities | 236,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,509,256,000USD | 1,539,637,000USD | 1,579,664,000USD | 946,258,000USD | 971,480,000USD | 786,233,000USD | 835,619,000USD | 892,930,000USD |
| Total Equity Including Noncontrolling Interest | 1,509,256,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 0USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 0USD | — | — | — | — | — | — | — |
| Net Receivables | 20,000,000USD | — | — | — | 40,000,000USD | 20,000,000USD | 947,000USD | 1,317,000USD |
| Property Plant Equipment Net | 81,071,000USD | 83,353,000USD | 85,526,000USD | 88,075,000USD | 94,617,000USD | 95,906,000USD | 97,864,000USD | 99,309,000USD |
| Accounts Payable | 8,918,000USD | 12,839,000USD | 4,014,999USD | 5,506,000USD | 5,781,000USD | 10,263,000USD | 5,989,000USD | 6,494,000USD |
| Short Term Debt | 12,119,000USD | 13,733,000USD | 13,756,000USD | 13,743,000USD | 13,666,000USD | 13,240,000USD | 13,112,000USD | 12,851,000USD |
| Common Stock | 8,000USD | 8,000USD | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD |
| Retained Earnings | -1,196,406,000USD | -1,135,195,000USD | -1,065,961,000USD | -978,980,000USD | -896,805,000USD | -820,191,000USD | -754,610,000USD | -683,858,000USD |
| Accumulated Other Comprehensive Income | -7,157,000USD | -4,194,000USD | 1,800,000USD | 1,501,000USD | 279,000USD | -58,000USD | -1,485,000USD | 1,931,000USD |
| Total Liab | — | 129,379,000USD | 163,148,000USD | 155,786,000USD | 159,588,000USD | 132,079,000USD | 142,416,000USD | 141,912,000USD |
| Other Current Liab | — | 36,071,000USD | 42,516,000USD | 29,047,000USD | 28,093,000USD | 24,010,000USD | 35,090,000USD | 27,163,000USD |
| Capital Stock | — | 8,000USD | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD |
| Cash | — | 144,090,000USD | 357,011,000USD | 112,949,000USD | 335,816,000USD | 89,966,000USD | 120,256,000USD | 110,718,000USD |
| Cash And Short Term Investments | — | 650,929,000USD | 848,276,000USD | 505,682,000USD | 665,445,000USD | 463,150,000USD | 488,744,000USD | 549,970,000USD |
| Net Debt | — | -63,621,000USD | -274,759,000USD | -28,952,000USD | -250,102,000USD | -3,636,000USD | -32,495,000USD | -22,487,000USD |
| Short Long Term Debt Total | — | 80,469,000USD | 82,252,000USD | 83,997,000USD | 85,714,000USD | 86,330,000USD | 87,761,000USD | 88,231,000USD |
| Long Term Investments | — | 894,724,000USD | 771,158,000USD | 473,055,000USD | 297,629,000USD | 312,335,000USD | 362,159,000USD | 361,035,000USD |
| Short Term Investments | — | 506,839,000USD | 491,265,000USD | 392,733,000USD | 329,629,000USD | 373,184,000USD | 368,488,000USD | 439,252,000USD |
| Property Plant Equipment Gross | — | 107,410,000USD | 107,653,000USD | 110,430,000USD | 114,823,000USD | 114,028,000USD | 113,937,000USD | 113,395,000USD |
| Common Stock Shares Outstanding | — | 97,534,269shares | 84,390,243shares | 87,300,286shares | 80,449,405shares | 80,146,531shares | 79,987,426shares | 76,125,975shares |
| Non Current Assets Total | — | 991,584,000USD | 871,597,999USD | 573,746,000USD | 402,741,000USD | 417,361,000USD | 467,767,000USD | 466,127,000USD |
| Non Current Liabilities Total | — | 66,736,000USD | 79,936,000USD | 84,211,000USD | 72,048,000USD | 73,090,000USD | 74,649,000USD | 75,380,000USD |
| Non Currrent Assets Other | — | 13,507,000USD | 9,113,999USD | 6,828,000USD | 4,675,000USD | 9,120,000USD | 7,744,000USD | 5,783,000USD |
| Net Working Capital | — | 614,789,000USD | 788,002,000USD | 456,723,000USD | 640,787,000USD | 441,962,000USD | 442,501,000USD | 502,183,000USD |
| Unclassified Non Current Liabilities | — | 66,736,000USD | 79,936,000USD | 84,211,000USD | 72,048,000USD | 73,090,000USD | 74,649,000USD | 75,380,000USD |
| Unclassified Equity | — | 2,679,010,000USD | 2,643,809,000USD | 1,923,723,000USD | 1,867,992,000USD | 1,606,468,000USD | 1,591,700,000USD | 1,574,843,000USD |
| Current Deferred Revenue | — | — | 22,925,000USD | 23,279,000USD | 40,000,000USD | 11,476,000USD | 13,576,000USD | 20,024,000USD |
| Unclassified Non Current Assets | — | — | — | 5,788,000USD | 5,820,000USD | — | — | — |
| Inventory | — | — | — | — | — | — | — | -1,317,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,742,812,000USD | 978,035,000USD | 575,759,000USD | 603,134,000USD | 605,905,000USD | 487,175,000USD | 116,702,000USD | 44,231,000USD |
| Other Current Assets | 22,938,000USD | 20,577,000USD | 11,674,000USD | 9,713,000USD | 8,720,000USD | 4,704,000USD | 888,000USD | 382,000USD |
| Total Liab | 163,148,000USD | 142,416,000USD | 180,788,000USD | 112,983,000USD | 146,267,000USD | 203,287,000USD | 191,108,000USD | 78,667,000USD |
| Total Stockholder Equity | 1,579,664,000USD | 835,619,000USD | 394,971,000USD | 490,151,000USD | 459,638,000USD | 283,888,000USD | -74,406,000USD | -34,436,000USD |
| Other Current Liab | 42,516,000USD | 35,090,000USD | 34,388,000USD | 27,805,000USD | 23,199,000USD | 10,436,000USD | 4,568,000USD | 2,329,000USD |
| Common Stock | 8,000USD | 7,000USD | 6,000USD | 6,000USD | 5,000USD | 4,000USD | — | — |
| Capital Stock | 8,000USD | 7,000USD | 6,000USD | 6,000USD | 5,000USD | 4,000USD | 0USD | 0USD |
| Retained Earnings | -1,065,961,000USD | -754,610,000USD | -530,752,000USD | -383,790,000USD | -228,982,000USD | -128,765,000USD | -76,456,000USD | -35,210,000USD |
| Cash | 357,011,000USD | 120,256,000USD | 109,966,000USD | 68,395,000USD | 47,976,000USD | 31,004,000USD | 76,015,000USD | 41,260,000USD |
| Cash And Short Term Investments | 848,276,000USD | 488,744,000USD | 374,881,000USD | 407,166,000USD | 442,418,000USD | 296,202,000USD | 91,957,000USD | 41,260,000USD |
| Total Current Assets | 871,214,000USD | 510,268,000USD | 405,317,000USD | 419,416,000USD | 451,273,000USD | 302,339,000USD | 92,845,000USD | 41,790,000USD |
| Total Current Liabilities | 83,212,000USD | 67,767,000USD | 85,691,000USD | 71,343,000USD | 92,542,000USD | 110,617,000USD | 34,570,000USD | 4,687,000USD |
| Current Deferred Revenue | 22,925,000USD | 13,576,000USD | 37,883,000USD | 35,260,000USD | 61,739,000USD | 92,552,000USD | 23,349,000USD | 2,319,000USD |
| Net Debt | -274,759,000USD | -32,495,000USD | -25,292,000USD | -51,060,000USD | -30,013,000USD | -13,011,000USD | -54,822,000USD | -40,565,000USD |
| Short Term Debt | 13,756,000USD | 13,112,000USD | 6,345,000USD | 3,943,000USD | 3,599,000USD | 3,261,000USD | 3,377,000USD | 302,000USD |
| Short Long Term Debt Total | 82,252,000USD | 87,761,000USD | 84,674,000USD | 17,335,000USD | 17,963,000USD | 17,993,000USD | 21,193,000USD | 695,000USD |
| Long Term Investments | 771,158,000USD | 362,159,000USD | 61,434,000USD | 152,328,000USD | 125,187,000USD | 162,531,000USD | — | — |
| Short Term Investments | 491,265,000USD | 368,488,000USD | 264,915,000USD | 338,771,000USD | 394,442,000USD | 265,198,000USD | 15,942,000USD | 0USD |
| Accounts Payable | 4,014,999USD | 5,989,000USD | 7,075,000USD | 4,335,000USD | 4,005,000USD | 4,368,000USD | 3,276,000USD | 2,056,000USD |
| Property Plant Equipment Net | 85,526,000USD | 97,864,000USD | 101,079,000USD | 22,243,000USD | 21,307,000USD | 20,686,000USD | 22,083,000USD | 2,242,000USD |
| Property Plant Equipment Gross | 107,653,000USD | 113,937,000USD | 111,519,000USD | 29,136,000USD | 25,223,000USD | 20,686,000USD | 22,083,000USD | 2,242,000USD |
| Accumulated Other Comprehensive Income | 1,800,000USD | -1,485,000USD | -552,000USD | -4,949,000USD | -660,000USD | -128,000USD | 6,000USD | -224,000USD |
| Common Stock Shares Outstanding | 84,390,243shares | 75,043,991shares | 58,365,499shares | 53,933,229shares | 47,989,023shares | 44,558,400shares | 44,529,542shares | 44,529,542shares |
| Non Current Assets Total | 871,597,999USD | 467,767,000USD | 170,442,000USD | 183,718,000USD | 154,632,000USD | 184,836,000USD | 23,857,000USD | 2,441,000USD |
| Non Current Liabilities Total | 79,936,000USD | 74,649,000USD | 95,097,000USD | 41,640,000USD | 53,725,000USD | 92,670,000USD | 156,538,000USD | 73,980,000USD |
| Non Currrent Assets Other | 9,113,999USD | 7,744,000USD | 7,929,000USD | 9,147,000USD | 8,138,000USD | 1,619,000USD | 1,774,000USD | 199,000USD |
| Net Working Capital | 788,002,000USD | 442,501,000USD | 319,626,000USD | 348,073,000USD | 358,731,000USD | 191,722,000USD | 58,275,000USD | 37,103,000USD |
| Unclassified Non Current Liabilities | 79,936,000USD | 74,649,000USD | 95,097,000USD | 13,144,000USD | -39,361,000USD | 14,632,000USD | 126,896,000USD | 73,664,000USD |
| Unclassified Equity | 2,643,809,000USD | 1,591,700,000USD | 926,263,000USD | 878,878,000USD | 689,270,000USD | 412,773,000USD | 2,044,000USD | — |
| Net Receivables | — | 947,000USD | 18,762,000USD | 2,537,000USD | 135,000USD | 1,433,000USD | 287,000USD | 148,000USD |
| Inventory | — | — | 1USD | -12,250,000USD | -8,990,000USD | -163,387,000USD | — | — |
| Other Liab | — | — | — | 28,248,000USD | 39,361,000USD | 77,938,000USD | 29,642,000USD | 158,000USD |
| Other Assets | — | — | — | 9,147,000USD | 8,138,000USD | 1,619,000USD | 1,774,000USD | 199,000USD |
| Non Current Liabilities Other | — | — | — | 248,000USD | 53,725,000USD | 100,000USD | — | 158,000USD |
| Net Tangible Assets | — | — | — | 490,151,000USD | 459,638,000USD | 283,888,000USD | -74,406,000USD | -34,436,000USD |
| Unclassified Non Current Assets | — | — | — | -9,147,000USD | -8,138,000USD | — | -1,774,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -2,319,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 4,052,000USD |
| Stock Based Compensation | 34,945,000USD |
| Change To Liabilities | 11,165,000USD |
| Change In Working Capital | 3,270,000USD |
| Operating Cash Flow | -142,905,000USD |
| Capital Expenditures | -907,000USD |
| Net Investments | -121,888,000USD |
| Investing Cash Flow | -122,795,000USD |
| Net Debt Issuance | -122,000USD |
| Common Stock Issuance | 32,577,000USD |
| Unclassified Financing Cash Flow | 733,000USD |
| Financing Cash Flow | 33,188,000USD |
| Change In Cash | -232,512,000USD |
| End Cash Flow | 130,299,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -69,234,000USD | -86,981,000USD | -82,175,000USD | -76,614,000USD | -65,581,000USD | -70,752,000USD | -62,487,000USD | -42,062,000USD |
| Depreciation | 2,022,000USD | 2,032,000USD | 2,149,000USD | 2,084,000USD | 2,048,000USD | 1,987,000USD | 1,987,000USD | 1,938,000USD |
| Stock Based Compensation | 16,007,000USD | 14,453,000USD | 15,802,000USD | 15,416,000USD | 14,233,000USD | 13,799,000USD | 14,904,000USD | 14,341,000USD |
| Other Non Cash Items | -2,730,000USD | -2,044,000USD | -1,364,000USD | -2,121,000USD | -2,525,000USD | -10,220,000USD | -5,955,000USD | -27,936,000USD |
| Change In Working Capital | -34,905,000USD | 5,793,000USD | 38,478,000USD | 1,351,000USD | -27,325,000USD | 3,402,000USD | 1,361,000USD | 10,783,000USD |
| Total Cash From Operating Activities | -88,840,000USD | -66,747,000USD | -27,110,000USD | -59,884,000USD | -79,150,000USD | -61,784,000USD | -50,190,000USD | -42,936,000USD |
| Capital Expenditures | -434,000USD | -106,000USD | -181,000USD | -695,000USD | -467,000USD | -936,000USD | -189,000USD | -4,689,000USD |
| Free Cash Flow | -89,274,000USD | -66,853,000USD | -27,291,000USD | -60,579,000USD | -79,617,000USD | -62,720,000USD | -50,001,000USD | -47,625,000USD |
| Investments | -142,406,000USD | -394,292,000USD | -235,299,000USD | 60,021,000USD | 48,615,000USD | 68,568,000USD | -157,680,000USD | 15,642,000USD |
| Total Cashflows From Investing Activities | -142,840,000USD | -394,398,000USD | -235,299,000USD | 60,021,000USD | 48,615,000USD | 68,568,000USD | -157,680,000USD | 15,642,000USD |
| Net Borrowings | -425,000USD | -416,000USD | -419,000USD | -382,000USD | -277,000USD | -293,000USD | -641,000USD | — |
| Total Cash From Financing Activities | 18,769,000USD | 705,219,000USD | 39,510,000USD | 245,726,000USD | 258,000USD | 2,765,000USD | 250,918,000USD | 1,412,000USD |
| Change In Cash | -212,911,000USD | 244,074,000USD | -222,899,000USD | 245,863,000USD | -30,277,000USD | 9,549,000USD | 43,048,000USD | -25,882,000USD |
| Begin Period Cash Flow | 362,811,000USD | 118,737,000USD | 341,636,000USD | 95,773,000USD | 126,050,000USD | 116,501,000USD | 73,453,000USD | 99,335,000USD |
| End Period Cash Flow | 149,900,000USD | 362,811,000USD | 118,737,000USD | 341,636,000USD | 95,773,000USD | 126,050,000USD | 116,501,000USD | 73,453,000USD |
| Other Cashflows From Investing Activities | 2,730,000USD | 2,045,000USD | -235,118,000USD | 2,121,000USD | 2,525,000USD | 69,504,000USD | -157,869,000USD | 20,331,000USD |
| Other Cashflows From Financing Activities | 18,769,000USD | 705,219,000USD | 39,929,000USD | — | 535,000USD | 3,058,000USD | 251,559,000USD | 1,764,000USD |
| Unclassified Investing Cash Flow | -2,730,000USD | — | 235,299,000USD | -1,426,000USD | -2,058,000USD | -68,568,000USD | 158,058,000USD | -15,642,000USD |
| Change To Account Receivables | — | 947,000USD | 40,000,000USD | -20,000,000USD | -19,053,000USD | 370,000USD | 386,000USD | 327,000USD |
| Issuance Of Capital Stock | — | 656,230,000USD | 35,377,000USD | 237,294,000USD | 0USD | 0USD | 246,506,000USD | 0USD |
| Unclassified Financing Cash Flow | — | -655,814,000USD | -35,377,000USD | 8,814,000USD | — | — | -246,506,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -311,351,000USD | -223,858,000USD | -146,962,000USD | -154,808,000USD | -100,217,000USD | -45,593,000USD | -41,246,000USD | -21,467,000USD |
| Depreciation | 8,313,000USD | 7,373,000USD | 3,565,000USD | 2,977,000USD | 2,397,000USD | 1,763,000USD | 825,000USD | 205,000USD |
| Stock Based Compensation | 59,904,000USD | 55,012,000USD | 43,118,000USD | 35,480,000USD | 24,972,000USD | 5,190,000USD | 1,196,000USD | 648,000USD |
| Other Non Cash Items | -5,023,000USD | -9,058,000USD | -11,800,000USD | 889,000USD | 5,825,000USD | 332,000USD | 54,338,000USD | 443,000USD |
| Change To Account Receivables | 947,000USD | 17,815,000USD | -16,226,000USD | -2,401,000USD | 577,000USD | -577,000USD | 148,000USD | -148,000USD |
| Change In Working Capital | 15,266,000USD | -23,970,000USD | 9,253,000USD | -37,623,000USD | -61,923,000USD | 124,867,000USD | 2,792,000USD | 2,308,000USD |
| Total Cash From Operating Activities | -232,891,000USD | -194,501,000USD | -102,826,000USD | -153,085,000USD | -128,946,000USD | 88,130,000USD | 17,905,000USD | -17,863,000USD |
| Capital Expenditures | -1,449,000USD | -12,838,000USD | -34,480,000USD | -2,836,000USD | -1,597,000USD | -9,096,000USD | -532,000USD | -1,356,000USD |
| Free Cash Flow | -234,340,000USD | -207,339,000USD | -137,305,999USD | -155,921,000USD | -130,543,000USD | 79,034,000USD | 17,373,000USD | -19,219,000USD |
| Investments | -519,612,000USD | -404,077,000USD | 71,268,000USD | 20,519,000USD | -98,238,000USD | -422,588,000USD | -15,954,000USD | -15,954,000USD |
| Total Cashflows From Investing Activities | -521,061,000USD | -404,077,000USD | 139,886,000USD | 20,519,000USD | -99,835,000USD | -422,588,000USD | -16,486,000USD | -1,356,000USD |
| Net Borrowings | -1,494,000USD | -1,576,000USD | -76,000USD | -1,130,000USD | -849,000USD | -554,000USD | -371,000USD | -295,000USD |
| Total Cash From Financing Activities | 990,713,000USD | 608,851,000USD | 4,192,000USD | 152,999,000USD | 250,280,000USD | 289,262,000USD | 34,911,000USD | 52,932,000USD |
| Issuance Of Capital Stock | 928,901,000USD | 596,619,000USD | 0USD | 149,825,000USD | 243,106,000USD | 289,654,000USD | 35,208,000USD | 53,227,000USD |
| Change In Cash | 236,761,000USD | 10,273,000USD | 41,252,000USD | 20,433,000USD | 21,499,000USD | -45,196,000USD | 36,330,000USD | 33,713,000USD |
| Begin Period Cash Flow | 126,050,000USD | 115,777,000USD | 74,525,000USD | 54,092,000USD | 32,593,000USD | 77,789,000USD | 41,459,000USD | 7,746,000USD |
| End Period Cash Flow | 362,811,000USD | 126,050,000USD | 115,777,000USD | 74,525,000USD | 54,092,000USD | 32,593,000USD | 77,789,000USD | 41,459,000USD |
| Other Cashflows From Investing Activities | 8,879,000USD | 13,983,000USD | 174,366,000USD | 20,519,000USD | -5,807,000USD | -413,492,000USD | -15,954,000USD | — |
| Other Cashflows From Financing Activities | 990,713,000USD | 13,808,000USD | 4,268,000USD | 4,304,000USD | 8,023,000USD | 93,143,000USD | 35,282,000USD | 53,227,000USD |
| Unclassified Investing Cash Flow | -8,879,000USD | — | -71,268,000USD | -17,683,000USD | 5,807,000USD | 422,588,000USD | 15,954,000USD | 15,954,000USD |
| Unclassified Financing Cash Flow | -927,407,000USD | — | — | 145,521,000USD | 235,083,000USD | -79,616,000USD | -35,208,000USD | -53,227,000USD |
| Change To Inventory | — | — | 23,372,000USD | 2,401,000USD | 8,708,000USD | 6,879,000USD | -148,000USD | — |
| Change To Liabilities | — | — | — | 5,029,000USD | 12,739,000USD | 118,390,000USD | 53,895,000USD | 824,000USD |
| Sale Purchase Of Stock | — | — | — | 4,304,000USD | 8,023,000USD | 276,289,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | 20,433,000USD | 21,499,000USD | -45,196,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | 1,571,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.